Cricket Health, a San Francisco, CA-based tech-enabled provider of integrated kidney care, closed a $24m Series A funding round.
The round was led by new investor Oak HC/FT with participation from new investors Cigna Corporation, LifeForce Capital, iSeed Ventures, Joe Montana’s Liquid 2 Ventures, Rock Health co-founder Halle Tecco, and Virta Health co-founder Sami Inkinen and returning investors First Round Capital, Box Group, Nexus Ventures, Seven Peaks Ventures, Aberdare Management and LinkedIn CEO Jeff Weiner.
The company intends to use the funds to expand its tech-enabled programs and its clinical presence, including the ongoing development of care management for ESRD patients to delay the need for dialysis and the creation of new home dialysis and in-center programs.
Founded in 2015 by Arvind Rajan, Vince Kim, and James Chaukos, Cricket Health provides tech-enabled integrated nephrology and dialysis care to chronic kidney disease (CKD) and end stage renal disease (ESRD) patients. The company works with risk-bearing payers and health systems to identify high-risk patients before kidney failure and focuses on preserving kidney function as long as possible. Its treatment plan prioritizes slowing the progression of kidney failure, keeping patients out of the hospital, ensuring prepared transitions, and supporting patients on any ESRD treatment path. This is done by combining in one provider:
– a nephrology practice that provides remote, in-person, and at-home care;
– a multidisciplinary care team to coordinate care and manage outcomes;
– technology to provide patient education and 24-7 peer and clinical support; and
– dialysis care either at home or in redesigned centers.
In the last year, Cricket Health has added renowned nephrologist and Professor of Medicine at University of California, San Francisco Carmen A. Peralta, MD, MAS as its Chief Medical Officer and kidney care industry veteran Danny Shapiro, who previously served in senior roles at DaVita Kidney Care and Home Care Assistance, as its Chief Business Officer.
Its medical advisors include:
– Glenn Chertow, MD, Chief of the Division of Nephrology and Professor of Medicine at Stanford;
– Michael Shlipak, MD, MPH, Chief of General Internal Medicine at the San Francisco VA Medical Center and Professor of Medicine at University of California, San Francisco; and
– Joel Glickman, MD, FACP, Professor of Clinical Medicine, University of Pennsylvania.